Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplemental Tables 1-2 from Phase I Trial of Ipatasertib plus Atezolizumab Enhances PI3K/AKT Pathway Immune Responses in Solid Tumors and Refractory Glioblastoma
  1. Home
  2. Publications
  3. Supplemental Tables 1-2 from Phase I Trial of Ipatasertib plus Atezolizumab Enhances PI3K/AKT Pathway Immune Responses in Solid Tumors and Refractory Glioblastoma

Supplemental Tables 1-2 from Phase I Trial of Ipatasertib plus Atezolizumab Enhances PI3K/AKT Pathway Immune Responses in Solid Tumors and Refractory Glioblastoma

Authors:
  • CTCrescens Tiu
    Crescens Tiu
  • WYWing Yau
    Wing Yau
  • DSDiogo Silva
    Diogo Silva
  • NWNick Waldron
    Nick Waldron
  • MAMalaka Ameratunga
    Malaka Ameratunga
  • MSMariana Scaranti
    Mariana Scaranti
  • ABAndrea Biondo
    Andrea Biondo
  • LWLiam Welsh
    Liam Welsh
  • ACAntonia Creak
    Antonia Creak
  • TJTimothy L. Jones
    Timothy L. Jones
  • AMAndrew J. Martin
    Andrew J. Martin
  • LBLeslie Bridges
    Leslie Bridges

Open Access
Publisher website
Google Scholar
  • 3 August 2026
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1078-0432.33143130
Abstract
No abstract available
Keywords
  • CLINICAL TRIAL RESULTS
  • PHASE I CLINICAL TRIALS
  • IMMUNOLOGY
  • REGULATORY T CELLS
  • T CELL EXHAUSTION
  • IMMUNOTHERAPY
  • CHECKPOINT BLOCKADE
  • SMALL MOLECULE AGENTS
  • KINASE INHIBITORS
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.